SkinCeuticals, CeraVe, La Roche-Posay & Melanoma Research Alliance Launch Three-Year Partnership in the United States
An annual Team Science Award will be Issued to Researchers Studying Artificial Intelligence (AI)...
Read More
Tag: Melanoma
Novartis receives FDA approval of Tafinlar® + Mekinist® for adjuvant treatment of BRAF V600-mutant melanoma
Novartis announced that the US Food and Drug Administration (FDA) has approved Tafinlar® (dabrafenib) in combination with Mekinist® (trametinib) for the adjuvant treatment of patients with melanoma with BRAF V600E...
Read MorePromising new drug stops spread of melanoma by 90 percent
Michigan State University researchers have discovered that a chemical compound, and potential new drug, reduces the spread of melanoma cells by up to 90 percent. The man-made, small-molecule drug compound...
Read MoreASDS: Costs to treat non-melanoma skin cancers in line with costs for other cancers
While skin cancer remains a growing major public health problem, a recent study focusing instead on the disease’s economic impact miscommunicates those treatment costs relative to the price tag of (more…)
Read MorePain and itch may be signs of skin cancer
Asking patients if a suspicious skin lesion is painful or itchy may help doctors decide whether the spot is likely to be cancerous, according to a new study headed by (more…)
Read MoreMelanoma recurs after 10 years in 6% of patients
Recurrence of melanoma 10 or more years after initial treatment is more common than previously thought, occurring in more than one in 20 patients. However, according to a new study,...
Read MoreEditorial: SPOT Skin Cancer
Coco Chanel is often accredited with making the sun tan popular in the 1920s. Prior to that, having tanned skinned signified that you were a labourer or outdoor worker, thus signifying...
Read More
September/October 2023 Issue
